BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8090787)

  • 1. Identification of soluble forms of the fibroblast growth factor receptor in blood.
    Hanneken A; Ying W; Ling N; Baird A
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9170-4. PubMed ID: 8090787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid.
    Hanneken A; Baird A
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1192-6. PubMed ID: 7730030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2.
    Hanneken A; Maher PA; Baird A
    J Cell Biol; 1995 Mar; 128(6):1221-8. PubMed ID: 7896883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of fibroblast growth factor: alteration of receptor binding specificity.
    Seddon AP; Aviezer D; Li LY; Böhlen P; Yayon A
    Biochemistry; 1995 Jan; 34(3):731-6. PubMed ID: 7827030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity.
    Bellosta P; Talarico D; Rogers D; Basilico C
    J Cell Biol; 1993 May; 121(3):705-13. PubMed ID: 8387532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5.
    Clements DA; Wang JK; Dionne CA; Goldfarb M
    Oncogene; 1993 May; 8(5):1311-6. PubMed ID: 8386828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display.
    Xie B; Tassi E; Swift MR; McDonnell K; Bowden ET; Wang S; Ueda Y; Tomita Y; Riegel AT; Wellstein A
    J Biol Chem; 2006 Jan; 281(2):1137-44. PubMed ID: 16257968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fibroblast growth factor binding protein in human cerebral spinal fluid.
    Hanneken A; Frautschy S; Galasko D; Baird A
    Neuroreport; 1995 Apr; 6(6):886-8. PubMed ID: 7612876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glycine box: a determinant of specificity for fibroblast growth factor.
    Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution.
    Nagendra HG; Harrington AE; Harmer NJ; Pellegrini L; Blundell TL; Burke DF
    FEBS Lett; 2001 Jul; 501(1):51-8. PubMed ID: 11457455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
    Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.
    Wang F; Kan M; Yan G; Xu J; McKeehan WL
    J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.
    Mansukhani A; Dell'Era P; Moscatelli D; Kornbluth S; Hanafusa H; Basilico C
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3305-9. PubMed ID: 1373495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the intracellular domain of FGF receptor 2IIIb affects contact of the ectodomain with two FGF7 ligands.
    Uematsu F; Jang JH; Kan M; Wang F; Luo Y; McKeehan WL
    Biochem Biophys Res Commun; 2001 May; 283(4):791-7. PubMed ID: 11350054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
    Schlessinger J; Plotnikov AN; Ibrahimi OA; Eliseenkova AV; Yeh BK; Yayon A; Linhardt RJ; Mohammadi M
    Mol Cell; 2000 Sep; 6(3):743-50. PubMed ID: 11030354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
    Aviezer D; Safran M; Yayon A
    Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells.
    Feng S; Xu J; Wang F; Kan M; McKeehan WL
    Biochim Biophys Acta; 1996 Jan; 1310(1):67-73. PubMed ID: 9244177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.